Tenet Healthcare price target raised to $60 from $57 at Stephens

Stephens analyst Scott Fidel raised the firm’s price target on Tenet Healthcare to $60 from $57 and keeps an Equal Weight rating on the shares following the release of Q4 results and issuance of 2023 guidance. Though Tenet acknowledged that the second SCD development transaction is a year behind initial expectations in its earnings ramp, this "already likely seemed clear to the Street based on the past few quarterly updates," the firm said.